Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction

被引:50
作者
Muecke, Thomas [1 ]
Haarmann, Stephan [1 ]
Wolff, Klaus-Dietrich [1 ]
Hoelzle, Frank [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-81675 Munich, Germany
关键词
bisphosphonates; bone; fibula flap; iliac crest; jaw; osteonecrosis; therapy; microvascular reconstruction; MULTIPLE-MYELOMA PATIENTS; RISK-FACTORS; BONE; PAMIDRONATE; CANCER; PREVENTION; APOPTOSIS; EFFICACY;
D O I
10.1016/j.jcms.2008.12.004
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction: This report presents two patients who received treatment with bisphosphonates (BPs) and who subsequently developed BP related osteonecrosis of the jaws (BRONJ). The treatment of advanced cases with BRONJ is an area of investigation. The possibility of microvascular reconstruction in severe cases of BRONJ needs further investigation. Material and methods: Two patients with advanced BRONJ of the left mandible underwent radical resection and immediate bony reconstruction with a microvascular osteocutaneous fibula or iliac crest flap. Both patients had been treated initially without success using more conservative procedures. The progressive course of the disease and refractory pain indicated the need to perform radical resection and immediate reconstruction of the mandible. Results: Both patients underwent successful resection of the affected bone with immediate reconstruction by microvascular flap transfer. After reconstruction of the mandible and cover of the defects, both patients recovered well with good mandibular function. Conclusions: Radical resection followed by microvascular composite flap reconstruction is reliable in the management of patients with advanced BRONJ and can be considered as the fourth therapeutic stage. (C) 2008 European Association for Cranio-Maxillofacial Surgery
引用
收藏
页码:291 / 297
页数:7
相关论文
共 41 条
[2]  
Abu-Id MH, 2006, ORAL MAXILLOFAC SURG, V10, P73, DOI 10.1007/s10006-005-0670-0
[3]   Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].
Badros, A ;
Weikel, D ;
Salama, A ;
Goloubeva, O ;
Schneider, A ;
Rapoport, A ;
Fenton, R ;
Gahres, N ;
Sausville, E ;
Ord, R ;
Meiller, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952
[4]   Jaw osteonecrosis associated with bisphosphonates:: Multiple exposed areas and its relationship to teeth extractions.: Study of 20 cases [J].
Bagan, JV ;
Jimenez, Y ;
Murillo, J ;
Hernandez, S ;
Poveda, R ;
Sanchis, JM ;
Díaz, JM ;
Scully, C .
ORAL ONCOLOGY, 2006, 42 (03) :327-329
[5]   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].
Bamias, A ;
Kastritis, E ;
Bamia, C ;
Moulopoulos, LA ;
Melakopoulos, L ;
Bozas, G ;
Koutsoukou, V ;
Gika, D ;
Anagnostopoulos, A ;
Papadimitriou, C ;
Terpos, E ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587
[6]   Advances in the biology and treatment of myeloma bone disease [J].
Berenson, JR .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :11-16
[7]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[8]   Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, M ;
Blacklock, H ;
Bell, R ;
Simeone, JF ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :593-602
[9]   Breast cancer: Bisphosphonate therapy for metastatic bone disease [J].
Body, Jean-Jacques .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6258S-6263S
[10]  
BOONYAPAKORN T, 2008, ORAL ONCOL